Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-22-000147

President and CEO sold 4,522 shares at $1.33 ($6,014)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Brunn Carsten President and CEO 2022-12-05 Sale −4,522 $1.33 $6,014 544,283 D
Open-market sales · 4,522 sh · avg $1.33 · $6,014
Loading xslF345X03/wf-form4_167044782270489.xml…